Related Experiment Videos

Inhibition of DNA synthesis and oncogene expression in tumor cells by the biological factor DIF

K Letnansky1, M Vetterlein, C Shi

  • 1Institute of Applied and Experimental Oncology, University of Vienna, Austria.

Anticancer Research
|March 1, 1991
PubMed

Insights

Decidua inhibitory factor (DIF), found in bovine placentas, halts tumor DNA synthesis. This cancer research finding suggests DIF acts through cell surface receptors and calcium signaling to impact tumor cell growth.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Decidua inhibitory factor (DIF) is a regulatory molecule derived from the maternal bovine placenta.
  • Tumorigenesis involves uncontrolled cell proliferation and DNA synthesis.

Purpose of the Study:

  • To investigate the anti-tumorigenic properties of DIF.
  • To elucidate the mechanism of action for DIF in tumor cells.

Main Methods:

  • In vitro assays measuring thymidine incorporation into DNA.
  • Analysis of signal transduction pathways involving calcium mobilization.
  • Assessment of c-fos and c-myc gene expression.

Main Results:

  • DIF significantly inhibited thymidine incorporation into tumor cell DNA in a dose-dependent manner.
  • DIF-induced inhibition is mediated by a Ca2+ mobilizing signal transduction pathway.
  • Specific binding of DIF to tumor cell surface receptors was observed.
  • DIF action led to the inhibition of c-fos and c-myc expression and/or degradation.

Conclusions:

  • DIF exhibits potent anti-proliferative effects on various tumor cells.
  • The mechanism involves receptor-mediated calcium signaling and down-regulation of key oncogenes.
  • DIF represents a potential therapeutic target for cancer treatment.

Related Concept Videos